Skip to main content
. Author manuscript; available in PMC: 2017 Feb 17.
Published in final edited form as: Cancer Prev Res (Phila). 2009 Dec 1;2(12):1015–1022. doi: 10.1158/1940-6207.CAPR-09-0099

Fig. 2.

Fig. 2

Pharmacokinetic profiles of aflatoxin equivalents from plasma samples collected at 0.25, 0.5, 0.45, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, and 8.0 h. Aflatoxin concentration is derived from AMS analysis based on total 14C from aliquots of plasma samples and is presented as mean ± SD (n = 3 independent trials).